Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $400.9 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.46% year-over-year to $400.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 2.25% YoY) and the FY2025 annual result came in at $405.9 million, up 1.6% from the prior year.
• Liabilities and Shareholders Equity declined to $400.9 million in Q1 2026 per BLFS's latest filing, from $405.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $544.3 million in Q1 2022 and bottomed at $375.0 million in Q2 2024.
• The 5-year median for Liabilities and Shareholders Equity is $405.9 million (2025), against an average of $423.3 million.
• Peak annual rise in Liabilities and Shareholders Equity reached 126.76% in 2022, while the deepest fall reached 18.77% in 2022.
• Tracing BLFS's Liabilities and Shareholders Equity over 5 years: stood at $450.2 million in 2022, then dropped by 8.33% to $412.7 million in 2023, then fell by 3.2% to $399.5 million in 2024, then grew by 1.6% to $405.9 million in 2025, then slipped by 1.23% to $400.9 million in 2026.
• Per Business Quant, the three latest BLFS Liabilities and Shareholders Equity figures stand at $400.9 million (Q1 2026), $405.9 million (Q4 2025), and $392.1 million (Q3 2025).

Peer Comparison